Tectonic Therapeutic Inc (TECX)

Currency in USD
21.310
-0.100(-0.47%)
Closed·
21.3100.000(0.00%)
·
TECX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
20.80421.720
52 wk Range
13.70061.070
Key Statistics
Prev. Close
21.31
Open
21.29
Day's Range
20.804-21.72
52 wk Range
13.7-61.07
Volume
256.65K
Average Volume (3m)
501.19K
1-Year Change
-55.19%
Book Value / Share
14.3
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TECX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
78.714
Upside
+269.38%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Tectonic Therapeutic Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Tectonic Therapeutic Inc Company Profile

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company’s lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.

Compare TECX to Peers and Sector

Metrics to compare
TECX
Peers
Sector
Relationship
P/E Ratio
−5.9x−6.6x−0.6x
PEG Ratio
−0.090.020.00
Price/Book
1.5x6.5x2.6x
Price / LTM Sales
-11.7x3.2x
Upside (Analyst Target)
255.0%91.6%41.8%
Fair Value Upside
Unlock−19.9%5.1%Unlock

Analyst Ratings

8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 78.714
(+269.38% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Oppenheimer
Buy80.00+275.41%-MaintainOct 30, 2025
Wells Fargo
Buy101.00+373.96%-New CoverageOct 20, 2025
Mizuho
Buy85.00+298.87%-MaintainOct 14, 2025
Oppenheimer
Buy80.00+275.41%-New CoverageSep 03, 2025
Truist Securities
Buy64.00+200.33%-New CoverageJul 21, 2025

Earnings

Latest Release
Nov 06, 2025
EPS / Forecast
-1.02 / -0.13
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

TECX Income Statement

People Also Watch

27.67
OLMA
-1.81%
14.12
JANX
+0.21%
12.18
ARVN
-1.14%
13.530
VOR
-1.31%
3.120
QTTB
+2.97%

FAQ

What Is the Tectonic Therapeutic (TECX) Stock Price Today?

The Tectonic Therapeutic stock price today is 21.310

What Stock Exchange Does Tectonic Therapeutic Trade On?

Tectonic Therapeutic is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Tectonic Therapeutic?

The stock symbol for Tectonic Therapeutic is "TECX."

What Is the Tectonic Therapeutic Market Cap?

As of today, Tectonic Therapeutic market cap is 398.84M.

What Is Tectonic Therapeutic's Earnings Per Share (TTM)?

The Tectonic Therapeutic EPS (TTM) is -3.88.

From a Technical Analysis Perspective, Is TECX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Tectonic Therapeutic Stock Split?

Tectonic Therapeutic has split 1 times.

How Many Employees Does Tectonic Therapeutic Have?

Tectonic Therapeutic has 51 employees.

What is the current trading status of Tectonic Therapeutic (TECX)?

As of Dec 24, 2025, Tectonic Therapeutic (TECX) is trading at a price of 21.310, with a previous close of 21.310. The stock has fluctuated within a day range of 20.804 to 21.720, while its 52-week range spans from 13.700 to 61.070.

What Is Tectonic Therapeutic (TECX) Price Target According to Analysts?

The average 12-month price target for Tectonic Therapeutic is USD78.71429, with a high estimate of USD101 and a low estimate of USD64. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +269.38% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.